IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
Events
IntegraGen to present at 6th annual Portzamparc MidCap Conference – April 10, 2019
-
Press releases
IntegraGen and Advanced Biological Laboratories sign global licensing agreement for the commercialization of miRpredX test
-
Press releases
IntegraGen Reports Revenue of €6.9 million for 2018 (+11%) and Cash Position of €4.0 million